The Risk of Revision After Primary Total Hip Arthroplasty Among Statin Users
- 1 May 2010
- journal article
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 92 (5), 1063-1072
- https://doi.org/10.2106/jbjs.h.01805
Abstract
49 patients from the Danish Hip Arthroplasty Registry who underwent revision of a primary total hip replacement in the period from 1996 to 2005 and matched them, using propensity score matching, with 2349 controls with a total hip replacement who had not had a revision. Using conditional logistic regression, we estimated the relative risk of revision due to all causes and due to specific causes according to postoperative statin use. Results: The ten-year cumulative implant revision rate in the underlying cohort of 57,581 total hip arthroplasties from the registry was 8.9% (95% confidence interval, 8.4% to 9.4%). Postoperative statin use was associated with an adjusted relative risk of revision of 0.34 (95% confidence interval, 0.28 to 0.41) compared with no use of statin. Statin use was associated with a reduced risk of revision due to deep infection, aseptic loosening, dislocation, and periprosthetic fracture. No difference in the risk of revision due to pain or implant failure was found between statin users and nonusers. Conclusions: The use of statins was associated with a substantially lower revision risk following primary total hip arthroplasty. Statins, however, should not be prescribed to healthy patients undergoing total hip arthroplasty in order to improve the longevity of the replacement until further studies have confirmed our finding and the mechanisms for this association have been clarified. Level of Evidence: Therapeutic Level III. See Instructions to Authors for a complete description of levels of evidence....Keywords
This publication has 28 references indexed in Scilit:
- Statins attenuate polymethylmethacrylate-mediated monocyte activationActa Orthopaedica, 2008
- Locally delivered lovastatin nanoparticles enhance fracture healing in ratsJournal of Orthopaedic Research, 2007
- Effects of statins on bone mineral density: A meta-analysis of clinical studiesBone, 2007
- Statins and fracture risk. A systematic reviewPharmacoepidemiology and Drug Safety, 2007
- Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrationsOsteoporosis International, 2006
- Promotion of bone formation by simvastatin in polyethylene particle-induced osteolysisBiomaterials, 2005
- Simvastatin Improves Fracture Healing in MiceJournal of Bone and Mineral Research, 2002
- Statin Given Perorally to Adult Rats Increases Cancellous Bone Mass and Compressive StrengthCalcified Tissue International, 2001
- Non-lipid-related effects of statinsAnnals of Medicine, 2000
- Stimulation of Bone Formation in Vitro and in Rodents by StatinsScience, 1999